BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 27855069)

  • 1. Activity of Tedizolid in Methicillin-Resistant Staphylococcus epidermidis Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Schuetz AN; Mandrekar JN; Patel R
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
    Park KH; Greenwood-Quaintance KE; Mandrekar J; Patel R
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6568-6572. PubMed ID: 27550347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Different Antistaphylococcal Therapies, Alone or Combined, in a Rat Model of Methicillin-Resistant Staphylococcus epidermidis Osteitis without Implant.
    Albac S; Labrousse D; Hayez D; Anzala N; Bonnot D; Chavanet P; Aslangul E; Croisier D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Vergidis P; Schmidt-Malan SM; Mandrekar JN; Steckelberg JM; Patel R
    J Infect; 2015 Jun; 70(6):609-15. PubMed ID: 25576292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Use of Rifabutin and Rifapentine to Treat Methicillin-Resistant Staphylococcus aureus in a Rat Model of Foreign Body Osteomyelitis.
    Karau MJ; Schmidt-Malan SM; Albano M; Mandrekar JN; Rivera CG; Osmon DR; Oravec CP; Berry DJ; Abdel MP; Patel R
    J Infect Dis; 2020 Oct; 222(9):1498-1504. PubMed ID: 32914837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with linezolid or vancomycin in combination with rifampin is effective in an animal model of methicillin-resistant Staphylococcus aureus foreign body osteomyelitis.
    Vergidis P; Rouse MS; Euba G; Karau MJ; Schmidt SM; Mandrekar JN; Steckelberg JM; Patel R
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1182-6. PubMed ID: 21189340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes and Implications of the Disappearance of Rifampin Resistance in a Rat Model of Methicillin-Resistant Staphylococcus aureus Foreign Body Osteomyelitis.
    Brinkman CL; Tyner HL; Schmidt-Malan SM; Mandrekar JN; Patel R
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4481-8. PubMed ID: 25987614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampin-Based Combination Therapy Is Active in Foreign-Body Osteomyelitis after Prior Rifampin Monotherapy.
    Brinkman CL; Schmidt-Malan SM; Mandrekar JN; Patel R
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ceftaroline and rifampin, alone or combined, in a rat model of methicillin-resistant
    Albac S; Anzala N; Bonnot D; Mirfendereski H; Chavanet P; Croisier D
    Microbiol Spectr; 2023 Dec; 11(6):e0015323. PubMed ID: 37791959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infections.
    Schmidt-Malan SM; Greenwood Quaintance KE; Karau MJ; Patel R
    Diagn Microbiol Infect Dis; 2016 May; 85(1):77-9. PubMed ID: 26906190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.
    Domínguez-Herrera J; Docobo-Pérez F; López-Rojas R; Pichardo C; Ruiz-Valderas R; Lepe JA; Pachón J
    Antimicrob Agents Chemother; 2012 Feb; 56(2):613-7. PubMed ID: 22123684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
    J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Omadacycline in Rat Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
    Karau MJ; Schmidt-Malan SM; Cunningham SA; Mandrekar JN; Pritt BS; Keepers TR; Serio AW; Chitra S; Patel R
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170321. PubMed ID: 34723626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus.
    Garrigós C; Murillo O; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
    J Infect; 2011 Sep; 63(3):229-35. PubMed ID: 21763722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.
    Chuard C; Herrmann M; Vaudaux P; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2611-6. PubMed ID: 1810196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections.
    Littorin C; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1549-1552. PubMed ID: 28326447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
    Lucet JC; Herrmann M; Rohner P; Auckenthaler R; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2312-7. PubMed ID: 2128441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.
    Poeppl W; Lingscheid T; Bernitzky D; Schwarze UY; Donath O; Perkmann T; Kozakowski N; Plasenzotti R; Reznicek G; Burgmann H
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5111-6. PubMed ID: 24936591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms.
    Yan Q; Karau MJ; Raval YS; Patel R
    Int J Antimicrob Agents; 2018 Nov; 52(5):608-615. PubMed ID: 30048689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
    Domínguez-Herrera J; López-Rojas R; Smani Y; Labrador-Herrera G; Pachón J
    Int J Antimicrob Agents; 2016 Dec; 48(6):661-665. PubMed ID: 28128094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.